2021-11-15T13:46:28-06:00 2020-12-31 BDO USA LLP 330 E KILBOURN AVENUE SUITE 750 MILWAUKEE WI 53202 990 2020-01-01 451495723 American Academy of Allergy Asthma & Immunology Foundation Inc % EXECUTIVE DIRECTOR INC AMER 4142726071 555 East Wells Ste 1100 Milwaukee WI 53202 JONATHAN A BERNSTEIN SECRETARY-TREASURER 4142726071 2021-11-05 true JONATHAN A BERNSTEIN 999009999 Jacob Cook P01240455 4142725900 3 2020 2022-09-23 18:48:47Z GISELLE MOSNAIM MD MS 555 E WELLS STREET SUITE 1100 MILWAUKEE WI 53202 788145 false X www.aaaaifoundation.org X 2011 WI TO FIND TREATMENTS AND CURES FOR THE MILLIONS OF PEOPLE SUFFERING FROM ALLERGIES, ASTHMA AND OTHER IMMUNOLOGIC DISEASES BY SUPPORTING EDUCATION AND RESEARCH. 16 12 0 21 0 0 1451957 303036 0 0 430108 485109 -110787 -117275 1771278 670870 960000 960000 0 0 0 0 0 0 70183 249496 187999 1209496 1147999 561782 -477129 17829777 19499281 1312820 2031371 16516957 17467910 X TO SERVE ORGANIZATIONS THAT ARE COMMITTED TO IMPROVING PATIENTS' LIVES THROUGH SUPPORT OF RESEARCH AND TRAINING THAT ADVANCES THE PREVENTION, TREATMENT AND CURE OF ALLERGIES, ASTHMA AND OTHER IMMUNOLOGIC DISEASES; AND FOSTERING AND PROVIDING FINANCIAL SUPPORT FOR PROFESSIONAL CAREER DEVELOPMENT IN THE FIELD OF ALLERGY, ASTHMA AND IMMUNOLOGY TO INCREASE THE NUMBER AND QUALITY OF PERSONS INVOLVED IN SAID FIELD AND IMPROVE ACCESS TO TREATMENT AND CURE OF ALLERGIES, ASTHMA AND OTHER IMMUNOLOGY DISEASES. false false 997259 960000 0 THE FOUNDATION FUNDS FOUR FACULTY DEVELOPMENT AWARDS ANNUALLY. THESE RESEARCH AWARDS SUPPORT THE RESEARCH EFFORTS OF JUNIOR FACULTY MEMBERS IN THE FIELD OF ALLERGY/IMMUNOLOGY TO LEAD TO THE PREVENTION AND CURE OF ASTHMA AND ALLERGIC AND IMMUNOLOGIC DISEASE. 997259 true true false false false false false false false false false false false false false true false true false false false false false false true false false true false false false false false false false false false false false false false false false true false false false true 2 0 true 0 false true UC false false false true true false false false false false false X 16 12 false true false false false false false true true false false true true true true false false false false false WI X EXECUTIVE DIRECTOR INC 4142766445 555 E WELLS ST SUITE 1100 MILWAUKEE WI 53202 X SCOTT H SICHERER MD DIRECTOR 2.0 2.0 X 0 53333 0 DAVID A KHAN MD SECRETARY-TREASURER 2.0 5.0 X X 0 47250 0 LEONARD B BACHARIER MD DIRECTOR 2.0 2.0 X 0 34000 0 MARY BETH FASANO MD MSPH PRESIDENT 2.0 15.0 X X 0 33333 0 DAVID M LANG MD IMMEDIATE PAST-PRESIDENT 2.0 2.0 X X 0 1000 0 THOMAS A FLEISHER MD EXECUTIVE VICE PRESIDENT 2.0 20.0 X X 0 1000 0 CARLA DAVIS MD DIRECTOR 2.0 2.0 X 0 750 0 GISELLE MOSNAIM MD MS PRESIDENT-ELECT 2.0 5.0 X X 0 0 0 ROBERT A WOOD MD DIRECTOR THRU 03/2020 2.0 2.0 X 0 0 0 PAULA J BUSSE MD DIRECTOR 2.0 2.0 X 0 0 0 MELODY C CARTER MD DIRECTOR THRU 03/2020 2.0 2.0 X 0 0 0 TIMOTHY CRAIG DO DIRECTOR 2.0 2.0 X 0 0 0 CHITRA DINAKAR MD DIRECTOR 2.0 2.0 X 0 0 0 SHARON B MARKOVICS MD DIRECTOR 2.0 2.0 X 0 0 0 KELLY D STONE MD PHD DIRECTOR THRU 03/2020 2.0 2.0 X 0 0 0 PAUL V WILLIAMS MD DIRECTOR 2.0 2.0 X 0 0 0 SARBJIT SAINI MD DIRECTOR 2.0 2.0 X 0 0 0 FRANK VIRANT MD DIRECTOR 2.0 2.0 X 0 0 0 STUART ABRAMSON MD PHD AE-C DIRECTOR 2.0 2.0 X 0 0 0 KEVIN J KELLY MD DIRECTOR 2.0 2.0 X 0 0 0 TAMARA T PERRY MD DIRECTOR 2.0 2.0 X 0 0 0 0 170666 0 0 false false false EXECUTIVE DIRECTOR INC 555 E WELLS ST SUITE 1100 MILWAUKEE WI 53202 MANAGEMENT 148974 1 58295 244741 303036 0 485109 485109 0 0 0 0 0 0 0 58295 117275 -117275 -117275 0 0 0 0 0 0 0 670870 367834 960000 960000 0 0 0 0 0 0 0 0 0 140366 28073 42110 70183 0 3945 3945 0 0 33884 33884 0 0 9804 9186 618 0 0 0 0 0 0 0 0 0 0 1147999 997259 80557 70183 1266194 410457 0 0 0 0 -561948 136917 0 0 0 0 0 0 0 0 81020 6339 0 0 17044511 18945568 0 0 0 0 0 0 0 0 17829777 19499281 475 5471 1280000 1400000 32345 625900 0 0 0 0 0 0 0 0 0 0 0 0 1312820 2031371 X 0 0 16516957 17467910 16516957 17467910 17829777 19499281 -477129 1428082 X false true X true false X X X 1 AMERICAN ACADEMY OF ALLERGY ASTHMA AND IMMUNOLOGY INC 396061326 10 true 960000 0 1 960000 0 true false false false false false false false false false false false false false false true false RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false 0 0 X PART X, LINE 2: ASC 740 FOOTNOTE AAAAI FOUNDATION GENERALLY IS EXEMPT FROM FEDERAL AND STATE INCOME TAXES UNDER THE PROVISIONS OF SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE; HOWEVER, THE NET INCOME FROM CERTAIN ACTIVITIES OF THE ACADEMY MAY BE SUBJECT TO INCOME TAX AS UNRELATED BUSINESS INCOME. DURING 2020 AND 2019, THE ORGANIZATION DID NOT HAVE A PROVISION FOR INCOME TAXES. Benefit Dinner 56240 56240 15000 3000 31016 Run/Walk 2055 2055 68259 0 58295 58295 15000 3000 99275 117275 -117275 true The Trustees of Columbia University PO Box 29789 General Post Office New York NY 100879789 135598093 501(c)(3) 240000 Faculty Development Award University of North Carolina Chapel Hill 104 Airport Drive Suite 2200 CB 1 Chapel Hill NC 275991350 566001393 501(c)(3) 240000 Faculty Development Award Cincinnati Children's Hospital Medical Ctr 3333 Burnet Avenue ML 4900 Cincinnati OH 45229 310833936 501(c)(3) 240000 Faculty Development Award RectorVisitors of University of Virginia PO Box 400195 Charlottesville VA 229044195 546001796 501(c)(3) 240000 Faculty Development Award 4 SCHEDULE I, PART I, LINE 2: MONITORING THE USE OF GRANTS THERE IS AN AD HOC REVIEW COMMITTEE, MADE UP OF INDIVIDUAL MEMBERS WITHOUT ANY INSTITUTIONAL CONFLICTS, THAT MAKE SUGGESTIONS FOR APPLICATION AND AWARD OBJECTIVE MODIFICATIONS. THESE CHANGES SUGGESTED ARE THEN PRESENTED TO THE BOARD OF DIRECTORS FOR APPROVAL. FOR EACH GRANT AWARDED, A PROGRESS REPORT IS REQUIRED TO BE SUBMITTED TO THE FOUNDATION ON A 6-MONTH AND/OR ANNUAL BASIS, DEPENDING ON THE TYPE OF AWARD. THE PROGRESS REPORT IS REQUIRED TO OUTLINE THE FOLLOWING: 1) STATING THE ORIGINAL AIMS OF THE PROJECT AND IF THOSE AIMS HAVE CHANGED 2) SYNOPSIS OF RESEARCH PROGRESS TO DATE 3) ABSTRACTS OR OTHER PUBLICATIONS RESULTING FROM THE RESEARCH PROJECT 4) ANY ADDITIONAL PENDING FUNDING RESULTING FROM THE STUDIES PERFORMED IN THIS RESEARCH PROJECT 5) RESEARCHER'S PLANS AFTER THE AWARD TERM 6) A FULL ACCOUNTING OF THE AWARD EXPENDITURES TO DATE PART VI, SECTION A, LINE 1A THE EXECUTIVE COMMITTEE IS COMPRISED OF THE OFFICERS OF THE ORGANIZATION AND ONE 3RD-4TH YEAR AT-LARGE BOARD MEMBER. THE EXECUTIVE COMMITTEE SHALL EXECUTE AND MONITOR THE DIRECTIVES OF THE BOARD OF DIRECTORS AND MAY ACT ON BEHALF OF THE ORGANIZATION IN ANY MATTER WHEN THE BOARD OF DIRECTORS IS NOT IN SESSION, REPORTING TO THE BOARD OF DIRECTORS FOR ITS RATIFICATION OF THE EXECUTIVE COMMITTEE'S ACTIONS. PART VI, SECTION A, LINE 3 The American Academy of Allergy, Asthma and Immunology, a related organization, is in contract with Executive Director, Inc. (EDI), an association management company. EDI is also engaged to perform services for American Academy of Allergy, Asthma & Immunology Foundation, Inc. PART VI, SECTION B, LINE 11 The 990 is first reviewed by the finance committee, which is comprised of the officers of the organization. After full review, it is presented to the remaining board of directors for review and approval. The 990 is then signed by an officer of the organization, typically the Secretary-Treasurer. PART VI, SECTION B, LINE 12 B & C DISCLOSURE MUST BE MADE IN WRITING THROUGH THE USE OF AN OFFICIAL DISCLOSURE FORM OR VIA AN ONLINE MANAGEMENT SYSTEM. THE COMPLETED FORMS MUST BE RETURNED PRIOR TO THE COMMENCEMENT OF AN OFFICE TERM, AND THESE FORMS MUST BE UPDATED WHENEVER CIRCUMSTANCES REQUIRE OR ONCE PER CALENDAR YEAR, WHICHEVER IS SOONER. ALL INFORMATION DISCLOSED IS REVIEWED TO IDENTIFY CONFLICTS OF INTEREST AND TO GUIDE THE RESOLUTION OF THOSE CONFLICTS. FOR LEADERS, REVIEWS WILL BE COMPLETED BY AN APPROPRIATE AMERICAN ACADEMY OF ALLERGY, ASTHMA AND IMMUNOLOGY COMMITTEE OR EXECUTIVE BODY. FOR FACULTY, REVIEWS WILL BE COMPLETED BY THE CONTINUING MEDICAL EDUCATION COMMITTEE OR THE ANNUAL MEETING PROGRAM COMMITTEE, DEPENDING ON THE ACTIVITY IN WHICH THE FACULTY MEMBER WILL POTENTIALLY BE INVOLVED. FOR AUTHORS, REVIEWS WILL BE COMPLETED BY THE PRACTICE DIAGNOSTICS AND THERAPEUTICS COMMITTEE. IN ALL CASES, AN INDIVIDUAL'S DISCLOSURE WILL BE REVIEWED IN THE CONTEXT OF THE ACTIVITY IN WHICH S/HE WILL POTENTIALLY BE PARTICIPATING. IF A CONFLICT OF INTEREST IS IDENTIFIED, THE REVIEWERS WILL BE ASKED TO IDENTIFY AN APPROPRIATE MECHANISM FOR RESOLVING THE CONFLICT. THIS COULD POTENTIALLY INCLUDE ASKING THE INDIVIDUAL TO ALTER THE RELATIONSHIP WHICH CREATES THE CONFLICT OR REMOVING THE INDIVIDUAL FROM INVOLVEMENT IN THE ACTIVITY. THE RESULTS OF EACH REVIEW WILL BE COMMUNICATED TO THE INDIVIDUAL AND THE ORGANIZATION PLANNING THE ACTIVITY TO FACILITATE THE RESOLUTION OF THE CONFLICT. THE INDIVIDUAL WILL BE EXPECTED TO DISCLOSE TO THE APPROPRIATE AUDIENCE ANY RELATIONSHIPS THAT WERE FOUND TO BE, OR TO PRESENT THE POTENTIAL FOR, CONFLICTS OF INTEREST BY THE REVIEWER. IF A CANDIDATE FOR ANY AWARD WORKS IN THE LABORATORY, DEPARTMENT OR INSTITUTION OF A COMMITTEE MEMBER, THAT COMMITTEE MEMBER WILL NOT BE PERMITTED TO VOTE OR SUBMIT ANY SCORE FOR THAT APPLICATION. COMMITTEE MEMBERS WILL ALSO EXCUSE THEMSELVES FROM THE REVIEW PROCEDURE IF THEY ARE ACTIVELY COLLABORATING WITH THE CANDIDATE OR HIS OR HER MENTOR. SUCH CONFLICTS MUST BE DISCLOSED PRIOR TO THE CONFERENCE CALL. AT THE DISCRETION OF THE CHAIRPERSON, THE COMMITTEE MEMBER MAY BE PERMITTED TO REMAIN ON THE CONFERENCE CALL BUT CANNOT PARTICIPATE IN THE DISCUSSION OF THAT APPLICATION IN ANY WAY UNLESS SPECIFICALLY REQUESTED TO PROVIDE ANY POINT OF CLARIFICATION BY ANOTHER COMMITTEE MEMBER. THE EXCEPTION TO THIS IS IF THE CANDIDATES WORK DIRECTLY IN THE LABORATORY OF THE COMMITTEE MEMBER, IN WHICH CASE THE COMMITTEE MEMBER MAY BE ASKED TO DISCONNECT FROM THE CONFERENCE CALL WHILE THAT APPLICATION IS DISCUSSED. PART VI, SECTION B, LINE 15 A & B AMERICAN ACADEMY OF ALLERGY, ASTHMA & IMMUNOLOGY FOUNDATION, INC. IS MANAGED BY EXECUTIVE DIRECTOR, INC., A FOR-PROFIT MANAGEMENT COMPANY. AMERICAN ACADEMY OF ALLERGY, ASTHMA & IMMUNOLOGY FOUNDATION, INC. HAS NO OFFICIAL EMPLOYEES, AS STAFF ASSIGNED TO AMERICAN ACADEMY OF ALLERGY, ASTHMA & IMMUNOLOGY FOUNDATION, INC. ARE EMPLOYEES OF THE MANAGEMENT COMPANY. AMERICAN ACADEMY OF ALLERGY, ASTHMA & IMMUNOLOGY FOUNDATION, INC. ALSO DOES NOT HAVE ANYONE THAT FITS THE DESCRIPTION OF A KEY EMPLOYEE. THE CONTRACTED MANAGEMENT FEE IS REVIEWED YEARLY BY THE BOARD OF DIRECTORS. PART VI, SECTION C, LINE 19 AMERICAN ACADEMY OF ALLERGY, ASTHMA & IMMUNOLOGY FOUNDATION, INC. MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FORM 990 AVAILABLE FOR PUBLIC INSPECTION UPON REQUEST. REQUESTED DOCUMENTS ARE PROVIDED WITHIN A REASONABLE TIME FRAME. AM ACAD OF ALLERGY ASTHMA & IMMUNOLOGY 555 EAST WELLS STREET SUITE 1100 MILWAUKEE WI 53202 396061326 EDUCATION WI 501(C)(3) 10 NA false false false false false false false false false false false false false false false false false false false false